<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="35457">Angiotensin-converting enzyme inhibitors</z:chebi> (ACE-I) and angiotensin receptor blockers (ARB) posses multiple beneficial effects such as cardioprotection, cerebroprotection, nephroprotection which provide opportunity to select the most suitable drug for the target vascular bed (e.g. coronary, or cerebral circulation) </plain></SENT>
<SENT sid="1" pm="."><plain>In some clinical settings, combined therapy ACE-I with ARB (double blockage of the renin-angiotensin-aldosteron system) may appear the most effective </plain></SENT>
<SENT sid="2" pm="."><plain>These drugs (especially ARB) may successfully prevent <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> and play a protective role in <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Recently, it has been demonstrated that <z:chebi fb="0" ids="6541">losartan</z:chebi> is able to inhibit vasodilatation of the aorta in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, which might prevent <z:hpo ids='HP_0001699'>sudden death</z:hpo> due to aorta rupture </plain></SENT>
<SENT sid="4" pm="."><plain>An increasing role of ARB is most beneficial in hipotensive therapy (inhibition/regression of <z:hpo ids='HP_0000822'>hypertension</z:hpo>-related organ damage) </plain></SENT>
<SENT sid="5" pm="."><plain>With particular interest, results of the ONTARGET study are being awaited </plain></SENT>
<SENT sid="6" pm="."><plain>This study is focused on the effect of double blockage (<z:chebi fb="0" ids="8774">ramipril</z:chebi> and <z:chebi fb="0" ids="9434">telmisartan</z:chebi>) on reduction of the occurrence of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, <z:hpo ids='HP_0001297'>stroke</z:hpo>, and <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
</text></document>